FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:527-532 February 25, 1993 Number 8 Next

	Full Text Letters Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods The frequency of infection with multidrug-resistant Mycobacterium tuberculosis is increasing. We reviewed the clinical courses of 171 patients with pulmonary disease due to M. tuberculosis resistant to rifampin and isoniazid who were referred to our hospital between 1973 and 1983. The patients' records were analyzed retrospectively. Their regimens were selected individually and preferably included three medications that they had not been given previously and to which the strain was fully susceptible.

Results The 171 patients (median age, 46 years) had previously received a median of six drugs and shed bacilli that were resistant to a median of six drugs. Thus, their regimens were frequently not optimal. Of 134 patients with sufficient follow-up data, 87 (65 percent) responded to chemotherapy (as indicated by negative sputum cultures for at least three consecutive months); 47 patients (35 percent) had no response, as shown by continually positive cultures. The median stay in the hospital was more than seven months. In a multivariate analysis, an unfavorable response was significantly associated with a greater number of drugs received before the current course of therapy (odds ratio, 4.0; 95 percent confidence interval, 1.6 to 9.9; P<0.001) and with male sex (odds ratio, 2.5; 95 percent confidence interval, 1.1 to 6.2; P<0.03). Twelve of the patients with responses subsequently had relapses. The overall response rate was 56 percent over a mean period of 51 months. Of the 171 patients, 63 (37 percent) died, and 37 of these deaths were attributed to tuberculosis.

Conclusions For patients with pulmonary tuberculosis that is resistant to rifampin and isoniazid, even the best available treatment is often unsuccessful. Only about half of such patients eventually have negative sputum cultures despite carefully selected regimens administered for extended periods. Failure to control this resistant infection is associated with high mortality and ominous implications for the public health.

Source Information

From the Departments of Medicine (M.G., M.D.I., L.A.M., D.W., L.A., C.R.H.) and Biostatistics (L.A.), National Jewish Center for Immunology and Respiratory Medicine, Denver.

Address reprint requests to Dr. Goble at the National Jewish Center for Immunology and Respiratory Medicine, 1400 Jackson St. Annex, Rm. J203, Denver, CO 80206.

Full Text of this Article

Related Letters:

Drug-Resistant Tuberculosis in New York City
Gensheimer K. F., Joffe I., Israel H. L., Frieden T. R., Dooley S. W.
Extract | Full Text  
N Engl J Med 1993; 329:134-135, Jul 8, 1993. Correspondence

Multidrug-Resistant Tuberculosis
Iseman M. D., Goble M., Corrêa da Silva L. C., Corrêa da Silva L. M., Di Perri G., Vento S., Concia E., Cazzadori A., Telzak E. E., Sepkowitz K., Turett G.
Extract | Full Text  
N Engl J Med 1996; 334:267-269, Jan 25, 1996. Correspondence

Antituberculosis-Drug Resistance
Chan-Tack K. M., Diaz J. F., Geerligs W. A., van Altena R., van der Werf T. S., Pablos-Méndez A., Raviglione M. C., Nunn P.
Extract | Full Text  
N Engl J Med 1998; 339:1079-1080, Oct 8, 1998. Correspondence

This article has been cited by other articles:

• Abubakar, I, Moore, J, Drobniewski, F, Kruijshaar, M, Brown, T, Yates, M, Anderson, C, Smith, E G, Magee, J, Lipman, M, McMenamin, J, Ruddy, M, Watson, J M (2009). Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax 64: 512-515 [Abstract] [Full Text]  
• Kim, D. H., Kim, H. J., Park, S.-K., Kong, S.-J., Kim, Y. S., Kim, T.-H., Kim, E. K., Lee, K. M., Lee, S. S., Park, J. S., Koh, W.-J., Lee, C.-H., Kim, J. Y., Shim, T. S. (2008). Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis. Am. J. Respir. Crit. Care Med. 178: 1075-1082 [Abstract] [Full Text]  
• Akpaka, P. E., Baboolal, S., Clarke, D., Francis, L., Rastogi, N. (2008). Evaluation of Methods for Rapid Detection of Resistance to Isoniazid and Rifampin in Mycobacterium tuberculosis Isolates Collected in the Caribbean. J. Clin. Microbiol. 46: 3426-3428 [Abstract] [Full Text]  
• French, C. E., Glynn, J. R., Kruijshaar, M. E., Ditah, I. C., Delpech, V., Abubakar, I. (2008). The association between HIV and antituberculosis drug resistance. Eur Respir J 32: 718-725 [Abstract] [Full Text]  
• Jeong, Y. J., Lee, K. S. (2008). Pulmonary Tuberculosis: Up-to-Date Imaging and Management. Am. J. Roentgenol. 191: 834-844 [Abstract] [Full Text]  
• Condos, R., Hadgiangelis, N., Leibert, E., Jacquette, G., Harkin, T., Rom, W. N. (2008). Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis. Chest 134: 187-192 [Abstract] [Full Text]  
• Hillemann, D., Rusch-Gerdes, S., Richter, E. (2007). Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J. Clin. Microbiol. 45: 2635-2640 [Abstract] [Full Text]  
• Mohsen, T., Abou Zeid, A., Haj-Yahia, S. (2007). Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience. J. Thorac. Cardiovasc. Surg. 134: 194-198 [Abstract] [Full Text]  
• Somocurcio, J. G, Sotomayor, A., Shin, S., Portilla, S., Valcarcel, M., Guerra, D., Furin, J. (2007). Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax 62: 416-421 [Abstract] [Full Text]  
• Somoskovi, A., Dormandy, J., Mitsani, D., Rivenburg, J., Salfinger, M. (2006). Use of Smear-Positive Samples To Assess the PCR-Based Genotype MTBDR Assay for Rapid, Direct Detection of the Mycobacterium tuberculosis Complex as Well as Its Resistance to Isoniazid and Rifampin. J. Clin. Microbiol. 44: 4459-4463 [Abstract] [Full Text]  
• Chiang, C-Y., Enarson, D. A., Yu, M-C., Bai, K-J., Huang, R-M., Hsu, C-J., Suo, J., Lin, T-P. (2006). Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study. Eur Respir J 28: 980-985 [Abstract] [Full Text]  
• Kim, H. J., Kang, C. H., Kim, Y. T., Sung, S-W., Kim, J. H., Lee, S. M., Yoo, C-G., Lee, C-T., Kim, Y. W., Han, S. K., Shim, Y-S., Yim, J-J. (2006). Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J 28: 576-580 [Abstract] [Full Text]  
• Holtz, T. H., Sternberg, M., Kammerer, S., Laserson, K. F., Riekstina, V., Zarovska, E., Skripconoka, V., Wells, C. D., Leimane, V. (2006). Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome. ANN INTERN MED 144: 650-659 [Abstract] [Full Text]  
• Faustini, A, Hall, A J, Perucci, C A (2006). Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61: 158-163 [Abstract] [Full Text]  
• Gimferrer, J. M, Mestres, C. A (2005). Role of Surgery in Drug-Resistant Pulmonary Tuberculosis. Asian Cardiovasc. Thorac. Ann. 13: 201-202 [Full Text]  
• Chambers, H. F., Turner, J., Schecter, G. F., Kawamura, M., Hopewell, P. C. (2005). Imipenem for Treatment of Tuberculosis in Mice and Humans. Antimicrob. Agents Chemother. 49: 2816-2821 [Abstract] [Full Text]  
• Ormerod, L. P. (2005). Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 73-74: 17-24 [Abstract] [Full Text]  
• Granich, R. M., Oh, P., Lewis, B., Porco, T. C., Flood, J. (2005). Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003. JAMA 293: 2732-2739 [Abstract] [Full Text]  
• Caminero, J. A. (2005). Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 25: 928-936 [Abstract] [Full Text]  
• Lucas, G. M. (2005). Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother 55: 413-416 [Abstract] [Full Text]  
• Takeda, S.-i., Maeda, H., Hayakawa, M., Sawabata, N., Maekura, R. (2005). Current Surgical Intervention for Pulmonary Tuberculosis. Ann. Thorac. Surg. 79: 959-963 [Abstract] [Full Text]  
• Dhanireddy, S., Liles, W. C., Gates, G. A. (2005). Vestibular Toxic Effects Induced by Once-Daily Aminoglycoside Therapy. Arch Otolaryngol Head Neck Surg 131: 46-48 [Full Text]  
• Moore, D. A. J., Mendoza, D., Gilman, R. H, Evans, C. A. W., Hollm Delgado, M.-G., Guerra, J., Caviedes, L., Vargas, D., Ticona, E., Ortiz, J., Soto, G., Serpa, J., the Tuberculosis Working Group in Peru, (2004). Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings. J. Clin. Microbiol. 42: 4432-4437 [Abstract] [Full Text]  
• Shiraishi, Y., Nakajima, Y., Katsuragi, N., Kurai, M., Takahashi, N. (2004). Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J. Thorac. Cardiovasc. Surg. 128: 523-528 [Abstract] [Full Text]  
• Di Perri, G., Bonora, S. (2004). Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54: 593-602 [Abstract] [Full Text]  
• Griffith, D. E. (2004). Treatment of Multidrug-resistant Tuberculosis: Should You Try This at Home?. Am. J. Respir. Crit. Care Med. 169: 1082-1083 [Full Text]  
• Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., Iseman, M. D. (2004). Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis. Am. J. Respir. Crit. Care Med. 169: 1103-1109 [Abstract] [Full Text]  
• Caminero, J. A., de March, P., Iseman, M. D. (2004). Statements of ATS, CDC, and IDSA on Treatment of Tuberculosis. Am. J. Respir. Crit. Care Med. 169: 316-317 [Full Text]  
• Schaaf, H S, Shean, K, Donald, P R (2003). Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch. Dis. Child. 88: 1106-1111 [Abstract] [Full Text]  
• Hovell, M. F., Sipan, C. L., Blumberg, E. J., Hofstetter, C. R., Slymen, D., Friedman, L., Moser, K., Kelley, N. J., Vera, A. Y. (2003). Increasing Latino Adolescents' Adherence to Treatment for Latent Tuberculosis Infection: A Controlled Trial. AJPH 93: 1871-1877 [Abstract] [Full Text]  
• Somoskovi, A., Song, Q., Mester, J., Tanner, C., Hale, Y. M., Parsons, L. M., Salfinger, M. (2003). Use of Molecular Methods To Identify the Mycobacterium tuberculosis Complex (MTBC) and Other Mycobacterial Species and To Detect Rifampin Resistance in MTBC Isolates following Growth Detection with the BACTEC MGIT 960 System. J. Clin. Microbiol. 41: 2822-2826 [Abstract] [Full Text]  
• Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., Dye, C. (2003). The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic. Arch Intern Med 163: 1009-1021 [Abstract] [Full Text]  
• Sterling, T. R, Lehmann, H. P, Frieden, T. R (2003). Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ 326: 574-574 [Abstract] [Full Text]  
• Hwang, H.-Y., Chang, C.-Y., Chang, L.-L., Chang, S.-F., Chang, Y.-H., Chen, Y.-J. (2003). Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J Med Microbiol 52: 239-245 [Abstract] [Full Text]  
• (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis. Am. J. Respir. Crit. Care Med. 167: 603-662 [Full Text]  
• Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcantara, F., Sanchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., Kapiga, S., Neuberg, D., Maguire, J. H., Kim, J. Y., Farmer, P. (2003). Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru. NEJM 348: 119-128 [Abstract] [Full Text]  
• Antoniou, K. M., Ferdoutsis, E., Bouros, D. (2003). Interferons and Their Application in the Diseases of the Lung. Chest 123: 209-216 [Abstract] [Full Text]  
• Cavusoglu, C., Hilmioglu, S., Guneri, S., Bilgic, A. (2002). Characterization of rpoB Mutations in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Turkey by DNA Sequencing and Line Probe Assay. J. Clin. Microbiol. 40: 4435-4438 [Abstract] [Full Text]  
• Drobniewski, F, Eltringham, I, Graham, C, Magee, J G, Smith, E G, Watt, B (2002). A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax 57: 810-816 [Abstract] [Full Text]  
• Burgos, M.V., Pym, A.S. (2002). Molecular epidemiology of tuberculosis. Eur Respir J 20: 54S-65s [Abstract] [Full Text]  
• Loddenkemper, R., Sagebiel, D., Brendel, A. (2002). Strategies against multidrug-resistant tuberculosis. Eur Respir J 20: 66S-77s [Abstract] [Full Text]  
• NITTA, A. T., KNOWLES, L. S., KIM, J., LEHNKERING, E. L., BORENSTEIN, L. A., DAVIDSON, P. T., HARVEY, S. M., DE KONING, M. L. (2002). Limited Transmission of Multidrug-Resistant Tuberculosis Despite a High Proportion of Infectious Cases in Los Angeles County, California. Am. J. Respir. Crit. Care Med. 165: 812-817 [Abstract] [Full Text]  
• El-Hajj, H. H., Marras, S. A. E., Tyagi, S., Kramer, F. R., Alland, D. (2001). Detection of Rifampin Resistance in Mycobacterium tuberculosis in a Single Tube with Molecular Beacons. J. Clin. Microbiol. 39: 4131-4137 [Abstract] [Full Text]  
• Furak, J., Trojan, I., Szoke, T., Tiszlavicz, L., Morvay, Z., Csada, E., Balogh, A. (2001). Surgical intervention for pulmonary tuberculosis: analysis of indications and perioperative data relating to diagnostic and therapeutic resections. Eur. J. Cardiothorac. Surg. 20: 722-727 [Abstract] [Full Text]  
• Bartfai, Z., Somoskovi, A., Kodmon, C., Szabo, N., Puskas, E., Kosztolanyi, L., Farago, E., Mester, J., Parsons, L. M., Salfinger, M. (2001). Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe Assay. J. Clin. Microbiol. 39: 3736-3739 [Abstract] [Full Text]  
• Brewer, T. F., Heymann, S. J., Krumplitsch, S. M., Wilson, M. E., Colditz, G. A., Fineberg, H. V. (2001). Strategies to Decrease Tuberculosis in US Homeless Populations: A Computer Simulation Model. JAMA 286: 834-842 [Abstract] [Full Text]  
• Narita, M., Alonso, P., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., Ashkin, D. (2001). Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994-1997. Chest 120: 343-348 [Abstract] [Full Text]  
• Tahaoglu, K., Torun, T., Sevim, T., Atac, G., Kir, A., Karasulu, L., Ozmen, I., Kapakli, N. (2001). The Treatment of Multidrug-Resistant Tuberculosis in Turkey. NEJM 345: 170-174 [Abstract] [Full Text]  
• Ruiz-Serrano, M. J., Alcalá, L., Martínez, L., Díaz, M., Marín, M., González-Abad, M. J., Bouza, E. (2000). In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to First-Line Antituberculosis Drugs. Antimicrob. Agents Chemother. 44: 2567-2568 [Abstract] [Full Text]  
• Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baez, J., Kochi, A., Dye, C., Raviglione, M. C. (2000). Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis: Treatment Outcomes in 6 Countries. JAMA 283: 2537-2545 [Abstract] [Full Text]  
• Horsburgh, C. R. Jr (2000). The Global Problem of Multidrug-Resistant Tuberculosis: The Genie Is out of the Bottle. JAMA 283: 2575-2576 [Full Text]  
• Enarson, D. A. (2000). Resistance to Antituberculosis Medications: Hard Lessons to Learn. Arch Intern Med 160: 581-582 [Full Text]  
• Granich, R. M., Balandrano, S., Santaella, A. J., Binkin, N. J., Castro, K. G., Marquez-Fiol, A., Anzaldo, G., Zarate, M., Jaimes, M. L., Velazquez-Monroy, O., Salazar, L., Alvarez-Lucas, C., Kuri, P., Flisser, A., Santos-Preciado, J., Ruiz-Matus, C., Tapia-Conyer, R., Tappero, J. W. (2000). Survey of Drug Resistance of Mycobacterium tuberculosis in 3 Mexican States, 1997. Arch Intern Med 160: 639-644 [Abstract] [Full Text]  
• Yew, W. W., Chan, C. K., Chau, C. H., Tam, C. M., Leung, C. C., Wong, P. C., Lee, J. (2000). Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens. Chest 117: 744-751 [Abstract] [Full Text]  
• DROBNIEWSKI, F.A., WATTERSON, S.A., WILSON, S.M., HARRIS, G.S. (2000). A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol 49: 271-278 [Abstract] [Full Text]  
• Drobniewski, F. A., More, P. G., Harris, G. S. (2000). Differentiation of Mycobacterium tuberculosis Complex and Nontuberculous Mycobacterial Liquid Cultures by Using Peptide Nucleic Acid-Fluorescence In Situ Hybridization Probes. J. Clin. Microbiol. 38: 444-447 [Abstract] [Full Text]  
• Yuen, L. K. W., Leslie, D., Coloe, P. J. (1999). Bacteriological and Molecular Analysis of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated in Australia. J. Clin. Microbiol. 37: 3844-3850 [Abstract] [Full Text]  
• Hirano, K., Abe, C., Takahashi, M. (1999). Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe Assay. J. Clin. Microbiol. 37: 2663-2666 [Abstract] [Full Text]  
• Sung, S.-W., Kang, C. H., Kim, Y. T., Han, S. K., Shim, Y.-S., Kim, J. H. (1999). Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur. J. Cardiothorac. Surg. 16: 187-193 [Abstract] [Full Text]  
• FLAMENT-SAILLOUR, M., ROBERT, J., JARLIER, V., GROSSET, J. (1999). Outcome of Multi-drug-resistant Tuberculosis in France . A Nationwide Case-Control Study. Am. J. Respir. Crit. Care Med. 160: 587-593 [Abstract] [Full Text]  
• Hellyer, T. J., DesJardin, L. E., Hehman, G. L., Cave, M. D., Eisenach, K. D. (1999). Quantitative Analysis of mRNA as a Marker for Viability of Mycobacterium tuberculosis. J. Clin. Microbiol. 37: 290-295 [Abstract] [Full Text]  
• Miyazaki, E., Miyazaki, M., Chen, J. M., Chaisson, R. E., Bishai, W. R. (1999). Moxifloxacin (BAY12-8039), a New 8-Methoxyquinolone, Is Active in a Mouse Model of Tuberculosis. Antimicrob. Agents Chemother. 43: 85-89 [Abstract] [Full Text]  
• Chan-Tack, K. M., Diaz, J. F., Geerligs, W. A., van Altena, R., van der Werf, T. S., Pablos-Mendez, A., Raviglione, M. C., Nunn, P. (1998). Antituberculosis-Drug Resistance. NEJM 339: 1079-1080 [Full Text]  
• Farmer, P., Kim, J. Y. (1998). Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus". BMJ 317: 671-674 [Full Text]  
• Joint Tuberculosis Committee of the British Thorac, (1998). Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53: 536-548 [Abstract] [Full Text]  
• Pablos-Mendez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S.B., Kim, S. J., Chaulet, P., Nunn, P., The World Health Organization-International Union, (1998). Global Surveillance for Antituberculosis-Drug Resistance, 1994-1997. NEJM 338: 1641-1649 [Abstract] [Full Text]  
• Purwantini, E., Daniels, L. (1998). Molecular Analysis of the Gene Encoding F420-Dependent Glucose-6-Phosphate Dehydrogenase from Mycobacterium smegmatis. J. Bacteriol. 180: 2212-2219 [Abstract] [Full Text]  
• McKeogh, M. M (1997). Tuberculosis in the hospice a cause for concern?. Palliat Med 11: 469-474 [Abstract]  
• Gravatt, B. (1997). Current Concepts in the Pharmacologic Treatment and Management of Tuberculosis. The Journal of School Nursing 13: 28-38 [Abstract]  
• Van Leuven, M., De Groot, M., Shean, K. P., Von Oppell, U. O., Willcox, P. A. (1997). Pulmonary Resection as an Adjunct in the Treatment of Multiple Drug-Resistant Tuberculosis. Ann. Thorac. Surg. 63: 1368-1372 [Abstract] [Full Text]  
• JOUVESHOMME, S., DAUTZENBERG, B., BAKDACH, H., DERENNE, J.-P. (1997). Preliminary Results of Collapse Therapy with Plombage for Pulmonary Disease Caused by Multidrug-resistant Mycobacteria. Am. J. Respir. Crit. Care Med. 157: 1609-1615 [Abstract] [Full Text]  
• Goad, J., Jaresko, G. (1997). Tuberculosis in the 90's. Journal of Pharmacy Practice 10: 105-121  
• Nitta, A. T., Davidson, P. T., de Koning, M. L., Kilman, R. J. (1996). Misdiagnosis of Multidrug-Resistant Tuberculosis Possibly Due to Laboratory-Related Errors. JAMA 276: 1980-1983 [Abstract]  
• Brewer, T. F., Heymann, S. J., Colditz, G. A., Wilson, M. E., Auerbach, K., Kane, D., Fineberg, H. V. (1996). Evaluation of Tuberculosis Control Policies Using Computer Simulation. JAMA 276: 1898-1903 [Abstract]  
• Liu, J., Barry, C. E. III, Besra, G. S., Nikaido, H. (1996). Mycolic Acid Structure Determines the Fluidity of the Mycobacterial Cell Wall. J. Biol. Chem. 271: 29545-29551 [Abstract] [Full Text]  
• Pablos-Mendez, A., Sterling, T. R., Frieden, T. R. (1996). The Relationship Between Delayed or Incomplete Treatment and All-Cause Mortality in Patients With Tuberculosis. JAMA 276: 1223-1228 [Abstract]  
• Bishai, W. R., Graham, N. M.H., Harrington, S., Page, C., Moore-Rice, K., Hooper, N., Chaisson, R. E. (1996). Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis. NEJM 334: 1573-1576 [Full Text]  
• Bloch, A. B., Simone, P. M., McCray, E., Castro, K. G. (1996). Preventing Multidrug-Resistant Tuberculosis. JAMA 275: 487-489 [Abstract]  
• Iseman, M. D., Goble, M., Correa da Silva, L. C., Correa da Silva, L. M., Di Perri, G., Vento, S., Concia, E., Cazzadori, A., Telzak, E. E., Sepkowitz, K., Turett, G. (1996). Multidrug-Resistant Tuberculosis. NEJM 334: 267-269 [Full Text]  
• Telzak, E. E., Sepkowitz, K., Alpert, P., Mannheimer, S., Medard, F., El-Sadr, W., Blum, S., Gagliardi, A., Salomon, N., Turett, G. (1995). Multidrug-Resistant Tuberculosis in Patients without HIV Infection. NEJM 333: 907-912 [Abstract] [Full Text]  
• Sterling, T. R., Brehm, W. T., Frieden, T. R. (1995). Isoniazid Preventive Therapy in Areas of High Isoniazid Resistance. Arch Intern Med 155: 1622-1628 [Abstract]  
• Treasure, R. L., Seaworth, B. J. (1995). Current Role of Surgery in Mycobacterium Tuberculosis. Ann. Thorac. Surg. 59: 1405-1407 [Abstract] [Full Text]  
• Jereb, J. A., Klevens, R. M., Privett, T. D., Smith, P. J., Crawford, J. T., Sharp, V. L., Davis, B. J., Jarvis, W. R., Dooley, S. W. (1995). Tuberculosis in Health Care Workers at a Hospital With an Outbreak of Multidrug-Resistant Mycobacterium tuberculosis. Arch Intern Med 155: 854-859 [Abstract]  
• (1995). Drug-resistant tuberculosis. DTB 33: 28-29 [Abstract] [Full Text]  
• Raviglione, M. C., Snider, D. E. Jr, Kochi, A. (1995). Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic. JAMA 273: 220-226 [Abstract]  
• Bloch, A. B., Sumartojo, E., Castro, K. G. (1994). Directly Observed Therapy for Tuberculosis in New York City-Reply. JAMA 272: 436-436 [Abstract]  
• Adal, K. A., Anglim, A. M., Palumbo, C. L., Titus, M. G., Coyner, B. J., Farr, B. M. (1994). The Use of High-Efficiency Particulate Air-Filter Respirators to Protect Hospital Workers from Tuberculosis -- A Cost-Effectiveness Analysis. NEJM 331: 169-173 [Abstract] [Full Text]  
• Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., Foresman, B. H. (1994). The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis. NEJM 330: 1179-1184 [Abstract] [Full Text]  
• Given, M. J., Khan, M. A., Reichman, L. B. (1994). Tuberculosis Among Patients With AIDS and a Control Group in an Inner-city Community. Arch Intern Med 154: 640-645 [Abstract]  
• Bloch, A. B., Cauthen, G. M., Onorato, I. M., Dansbury, K. G., Kelly, G. D., Driver, C. R., Snider, D. E. Jr (1994). Nationwide Survey of Drug-Resistant Tuberculosis in the United States. JAMA 271: 665-671 [Abstract]  
• Gittler, J. (1994). Controlling Resurgent Tuberculosis: Public Health Agencies, Public Policy, and Law. Journal of Health Politics, Policy and Law 19: 107-147 [Abstract]  
• Iseman, M. D. (1993). Treatment of Multidrug-Resistant Tuberculosis. NEJM 329: 784-791 [Full Text]  
• Selwyn, P. A. (1993). Tuberculosis and AIDS: Epidemiologic, Clinical, and Social Dimensions. J Law Med Ethics 21: 279-288  
• Gensheimer, K. F., Joffe, I., Israel, H. L., Frieden, T. R., Dooley, S. W. (1993). Drug-Resistant Tuberculosis in New York City. NEJM 329: 134-135 [Full Text]  
• Trachtenberg, A. I., Oravec, L., Roberson, D. W., Reichman, L. B., Mangura, B. T., Annas, G. J. (1993). The Law and Control of Tuberculosis. NEJM 329: 136-138 [Full Text]  
• Braun, M. M., Cote, T. R., Rabkin, C. S. (1993). Trends in Death With Tuberculosis During the AIDS Era. JAMA 269: 2865-2868 [Abstract]  
• Weinberger, S. E. (1993). Recent Advances in Pulmonary Medicine- Second of Two Parts. NEJM 328: 1462-1470 [Full Text]  
• Jacobs, W. Jr, Barletta, R., Udani, R, Chan, J, Kalkut, G, Sosne, G, Kieser, T, Sarkis, G., Hatfull, G., Bloom, B. (1993). Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260: 819-822 [Abstract]  
• (1993). MORE ON DRUG-RESISTANT TUBERCULOSIS. JWatch General 1993: 3-3 [Full Text]